| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |